Emma Schofield

Electronic energy transfer and collection in luminescent molecular rods containing ruthenium(II) and osmium(II) 2,2':6',2"-terpyridine complexes linked by thiophene-2,5-diyl spacers.

A rod-like polymer containing (Ru(terpy)2) units prepared by electrochemical coupling of pendant thienyl moieties.

Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.

Complexed nitrogen heterosuperbenzene: the coordinating properties of a remarkable ligand.

Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.

Photochemical expulsion of the neutral monodentate ligand L in Ru(terpy*)(diimine)(L)2+: a dramatic effect of the steric properties of the spectator diimine ligand.

Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis.

Structural development of free or coordinated 4'-(4-pyridyl)-2,2':6',2''-terpyridine ligands through N-alkylation: new strategies for metallamacrocycle formation.

Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.

Robust self-assembled monolayers of Ru(II) and Os(II) polypyridines on gold surfaces: exploring new potentials.

Quantitation of glycogen synthase kinase-3 sensitive proteins in neuronal membrane rafts.

Low serum progranulin predicts the presence of mutations: a prospective study.

Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.

The relationship between clinical and pathological variables in Richardson's syndrome.

Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.

What is your neurologic diagnosis? Fibrocartilaginous embolism in a cat.

Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.